Investor Day 2026 Download Presentation 6.4 MB Listen to the Full Presentation Watch Full Video Watch Investor Day by Chapter1.) Intro & Overview (Pravin U. Dugel, MD)2.) SOL-1 Data & Clinical Program Review (Nadia K. Waheed, MD, MPH)3.) U.S. Regulatory Strategy in Wet AMD (Peter K. Kaiser, MD)4.) NDA Submission Strategy (Peter K. Kaiser, MD & Arthur Ciociola, PhD)5.) Preparing for a Successful Launch (David Robinson)6.) SOL-R- Defining Non-Inferiority Success (Jeffrey S. Heier, MD)7.) KOL Perspectives (Featuring Arshad Khanani, MD; Lejla Vajzovic, MD; Darius Moshfeghi, MD)8.) Summary & Takeaways (Pravin U. Dugel, MD)9.) Audience Q&A (All) SOL-1 Phase 3 Data Presentation at Macula Society Download Presentation 6.6 MB Watch Full Video Watch By Chapter
1.) Intro & Overview (Pravin U. Dugel, MD)2.) SOL-1 Data & Clinical Program Review (Nadia K. Waheed, MD, MPH)3.) U.S. Regulatory Strategy in Wet AMD (Peter K. Kaiser, MD)4.) NDA Submission Strategy (Peter K. Kaiser, MD & Arthur Ciociola, PhD)5.) Preparing for a Successful Launch (David Robinson)6.) SOL-R- Defining Non-Inferiority Success (Jeffrey S. Heier, MD)7.) KOL Perspectives (Featuring Arshad Khanani, MD; Lejla Vajzovic, MD; Darius Moshfeghi, MD)8.) Summary & Takeaways (Pravin U. Dugel, MD)9.) Audience Q&A (All)
1.) Intro & Overview (Pravin U. Dugel, MD)2.) SOL-1 Data & Clinical Program Review (Nadia K. Waheed, MD, MPH)3.) U.S. Regulatory Strategy in Wet AMD (Peter K. Kaiser, MD)4.) NDA Submission Strategy (Peter K. Kaiser, MD & Arthur Ciociola, PhD)5.) Preparing for a Successful Launch (David Robinson)6.) SOL-R- Defining Non-Inferiority Success (Jeffrey S. Heier, MD)7.) KOL Perspectives (Featuring Arshad Khanani, MD; Lejla Vajzovic, MD; Darius Moshfeghi, MD)8.) Summary & Takeaways (Pravin U. Dugel, MD)9.) Audience Q&A (All)
